StatSpin: Testimonials: World Leader in stat sample preparation, multipurpose centrifuges, blood collection and processing devices and microhematocrit systems

STATSPIN REPORTS ON ALLIANCE WITH IDEXX LABORATORIES
AND THE SHIPMENT OF ITS 10,000th HIGH SPEED CENTRIFUGE TO THE
VETERINARY MARKET

      CHATSWORTH, CA, September 11, 2000 - StatSpin, Inc., a subsidiary of publicly traded International Remote Imaging Systems, Inc. (IRI-ASE), or IRIS® as it is known, announced today that it has shipped its 10,000th high-speed centrifuge under a purchase agreement with IDEXX Laboratories, of Westbrook, Maine. IDEXX Laboratories is a world leader in providing diagnostic equipment for veterinary applications, offering products to customers in over 50 countries.
      Dr. John A. O'Malley, Chairman, CEO and President commented, "We are proud of our long term business alliance with IDEXX. This relationship has proven to be fruitful and in both our interests. Relationships like this continue to reinforce my belief that there remains great revenue and profit potential for StatSpin."
      Since 1993,IDEXX has placed the StatSpin centrifuge along with its VetTest® Chemistry Analyzer to provide a complete in-clinic sample preparation and analysis system for veterinarians. The StatSpin centrifuge spins down whole blood to prepare plasma for the VetTest analyzer in as little as 30 seconds, thereby making diagnosis and treatment faster.
      According to Kathy Barber, IDEXX Product Manager for the VetTest system, "the StatSpin centrifuge is a perfect complement to our analyzer-it's small, quiet and incredibly fast, saving anywhere from 7 to 10 minutes in preparation time compared with standard laboratory centrifuges."
      IRIS is a highly regarded manufacturer and marketer of automated urinalysis imaging systems and medical devices used in hospital and reference clinical laboratories, worldwide. IRIS is a leader in the automated urinalysis workstation market with more than 400 installations. The StatSpin subsidiary, which manufactures and markets a line of centrifugal specimen preparation devices to the clinical and veterinary markets, has sold more than 30,000 of its micro centrifuge systems to date.

The comments made by Dr. O'Malley in this press release contain forward-looking statements made in reliance upon the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of StatSpin's industry and competition. IRIS refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.